Snapshot from Sep 18, 2026 at 07:00 UTC. For live data and tracking: View Live
Business Investor Relations

ProMIS Neurosciences September 2026 Conferences

Analysis based on 8 articles · First reported Sep 01, 2026 · Last updated Sep 01, 2026

Sentiment
10
Attention
1
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The announcement of conference participation is a routine investor relations activity with minimal direct market impact. It may modestly increase visibility and investor engagement for ProMIS Neurosciences, potentially supporting its stock price in the near term.

Biotechnology Healthcare

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines for neurodegenerative diseases, announced its participation in several investor conferences and events in September 2026. The company will present at the Cantor Global Healthcare Conference (September 9-11), Moody s Ratings Disruptive Growth & Life Sciences Conference (September 9-10), H.C. Wainwright 28th Annual Global Investment Conference (September 14-16), and Roth Healthcare Opportunities Conference (September 29), all in New York City. On September 21, World Alzheimer's Day, ProMIS will mark the occasion at the Nasdaq Tower. During these events, CEO Neil Warma, CMO Larry Altstiel, and VP of IR Carie Pierce will discuss the EpiSelect platform and PMN310, the lead candidate in the ongoing PRECISE-AD Phase 1b trial for early Alzheimer's disease. The company reported blinded 6-month interim data from the trial in July 2026, with 12-month topline data expected in early 2027.

70 ProMIS Neurosciences announced interim data timeline
40 ProMIS Neurosciences will present
30 ProMIS Neurosciences announced financial results
stock
ProMIS is the central entity, announcing its participation in multiple conferences to showcase its pipeline and clinical progress. The events provide a platform to communicate its EpiSelect platform and PMN310 trial data, potentially influencing investor perception.
Importance 100.0 Sentiment 10.0
per
As President and CEO, Neil Warma will represent ProMIS at several conferences, including a fireside chat at the Cantor conference. His presentations are key to conveying the company's strategy and clinical updates.
Importance 80.0 Sentiment 10.0
per
As Chief Medical Officer, Larry Altstiel will discuss the clinical aspects of PMN310 and the EpiSelect platform, providing scientific credibility to the company's presentations.
Importance 40.0 Sentiment 5.0
exch
Nasdaq will host ProMIS for a World Alzheimer's Day event at the Nasdaq Tower, providing a symbolic venue that highlights the company's mission and may increase visibility.
Importance 30.0 Sentiment 0.0
per
As VP of Investor Relations, Carie Pierce will facilitate investor communications and is the contact for investor relations, playing a supporting role in the events.
Importance 30.0 Sentiment 5.0
priv
Cantor Fitzgerald is hosting the Cantor Global Healthcare Conference, providing a venue for ProMIS to present. The conference is a routine industry event.
Importance 30.0 Sentiment 0.0
priv
Moody s Ratings is hosting the Disruptive Growth & Life Sciences Conference, where ProMIS will present. This is a standard investor conference.
Importance 20.0 Sentiment 0.0
priv
H.C. Wainwright is hosting its 28th Annual Global Investment Conference, where ProMIS will present. This is a routine industry event.
Importance 20.0 Sentiment 0.0
per
Pete Stavropoulos, a Cantor analyst, will participate in the fireside chat with Neil Warma, representing the analyst community's interest in ProMIS.
Importance 20.0 Sentiment 0.0
priv
Roth Capital Partners is hosting the Healthcare Opportunities Conference, where ProMIS will present. This is a standard investor conference.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.